Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples